Physician profile
Robert N Lee
NPI 1104069921
$561.33
in general payments reported to CMS, 2019-2025
12 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.64 · 2021: $41.79 · 2022: $53.03 · 2023: $60.98 · 2024: $188 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $229.33 | 2024-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $65.46 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $43.65 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $34.93 | 2022-2023 | Qelbree |
| Azurity Pharmaceuticals, INC. | $29.57 | 2025 | Alvesco |
| Merck Sharp & Dohme LLC | $29.16 | 2019-2021 | |
| Cranial Technologies, INC | $29.11 | 2022-2024 | Doc Band |
| Welch Allyn | $24.13 | 2021 | |
| Baxter Healthcare | $24.13 | 2022 | |
| Pfizer INC. | $17.85 | 2019 | |
| Ironshore Pharmaceuticals INC. | $17.18 | 2024 | |
| Kaleo, INC. | $16.83 | 2023 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.